Costly eye drug drives up region’s Medicare bills – Pacific Coast Business Times

Costly eye drug drives up region’s Medicare bills
Pacific Coast Business Times
Both drugs are used by ophthalmologists to treat wet age-related macular degeneration, or wet AMD, the leading cause of blindness in the elderly, although only Lucentis is technically approved for that use. The Lucentis rebates, though entirely legal

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment